The ankle-brachial index value in patients with purulent-necrotic complications of diabetic foot syndrome

Authors

  • B. O. Matviychuk Danylo Halytsky Lviv National Medical University Lviv, Ukraine, Ukraine
  • V. S. Zaremba Danylo Halytsky Lviv National Medical University Lviv, Ukraine, Ukraine
  • N. R. Fedchyshyn Danylo Halytsky Lviv National Medical University Lviv, Ukraine, Ukraine
  • O. P. Tsymbala Danylo Halytsky Lviv National Medical University Lviv, Ukraine, Ukraine

DOI:

https://doi.org/10.34287/MMT.2(41).2019.27

Abstract

Diabetes and predetermined him heavy purulent-necrotic complications is actual problem medicine today’s. It is proved that patients with diabetes have big risk to development of heart-vessel disease due to the development of atherosclerosis. Standard of diagnosis peripheral arterial disease of lower limb is finding ankle-brachia index (ABI). This method is good at definition of degree of arterial occlusion.

Purpose of the study. Purpose of the work: to analyse the diagnostic capability of ABI in patients who have purulent-necrotic complications of diabetic foot.

Material and methods. The prospective studies covered 218 patients. The average patients age 54,2 ± 10,3years, 45,5% of them – men. The mild form of disease was in 33,2%, moderate severity – in 45,2%, severe – in 21,6%. The duration of purulent-necrotic complications was 11,5 ± 1,2 days.

Results. We have seen that 128 patients have different degrees of macroangiopathy. in patients who performed amputation at the level of the thigh of ABI was 0,41 ± 0,13; at the level of the leg – 0,59 ± 0,12.

Conclusion. 1. Timely diagnosis is the basis of effective treatment of purulent necrotic complications of diabetic foot. 2. In treatment, it is necessary to take into account the indicators of ABI as the main diagnostic marker of peripheral artery disease of lower limb. 3. Definition of ABI is an objective and valuable predictive marker.

References

Fowkes FG, Murray GD, Butcher I, Heald CL et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300 (2): 197–208. DOI: 10.1001/jama.300.2.197.

American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–3341.DOI:10.2337/diacare.26.12.3333.

Lee AJ., Macgregor AS, Hau CM, Price JF et al. The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh Artery Study. British Journal of Haematology, 1999, 105, 648–654.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45 (suppl S): S5–67. DOI: 10.1016/j.jvs.2006.12.037.

Downloads

Published

2019-07-20

How to Cite

Matviychuk, B. O. ., Zaremba, V. S. ., Fedchyshyn, N. R. ., & Tsymbala, O. P. . (2019). The ankle-brachial index value in patients with purulent-necrotic complications of diabetic foot syndrome. Modern Medical Technology, (2), 59–61. https://doi.org/10.34287/MMT.2(41).2019.27